A recent study revealed the effectiveness of overcoming drug resistance in lung cancer therapy by combining miR495 and doxorubicin into a cancer cell membrane-coated silica nanoparticle, the results of which indicated that miR495 effectively down-regulated P-gp expression in multi-drug resistant cancer cells [94]. The gene discussed is PGP; the disease is cancer.